Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00227903 · ClinicalTrials.gov registry record · Phase 2

Therapeutic Substance Abuse Treatment in Pregnancy - 1

A Phase 2 study of Alcohol Abuse and Cocaine Abuse, sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase
168
Enrollment target
2
Study locations

NCT00227903 is a Phase 2 study of Alcohol Abuse and Cocaine Abuse that has completed, run by Yale University. The registered enrollment target is 168 participants, below the 709-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00227903, a Phase 2 study of Alcohol Abuse and Cocaine Abuse, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase
168 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is... To assess whether a behavioral treatment that combines motivational enhancement and cognitive skills training therapy (MET-CBT) is more effective than brief advice in: 1) decreasing use of a full range of psychoactive substances (e.g. marijuana, cocaine, methamphetamines, alcohol, nicotine, opioids) in pregnant substance using and dependent women; 2) decreasing HIV risk behavior; 3) improving birth outcomes (longer gestations and greater birth weight).

Interventions

  • BEHAVIORAL MI-CBT
  • BEHAVIORAL Brief Advice

Study Locations (2)

Connecticut

  • Bridgeport Hospital - Bridgeport
  • Yale-New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2004-09
Est. Completion 2010-08
Phase Phase 2

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT00227903

The ClinicalTrials.gov registry entry for NCT00227903 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 709-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (76% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which MI-CBT is the first listed.

NCT00227903 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00227903 about?

NCT00227903 is a clinical study titled "Therapeutic Substance Abuse Treatment in Pregnancy - 1". The purpose of this study is... To assess whether a behavioral treatment that combines motivational enhancement and cognitive skills training therapy (MET-CBT) is more effective than brief advice in: 1) decreasing use of a full range of psychoactive substances (e.g. marijuana, cocaine, methamphetami...

What is the current status of trial NCT00227903?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2004-09. Estimated completion is 2010-08.

What conditions does trial NCT00227903 study?

This clinical trial studies the following conditions: Alcohol Abuse, Cocaine Abuse, Marijuana Abuse.

What interventions are being tested in trial NCT00227903?

The interventions under investigation include: MI-CBT (BEHAVIORAL), Brief Advice (BEHAVIORAL).

Who is sponsoring clinical trial NCT00227903?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00227903 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.